Global Chemiluminescence Immunoassay Analyzer Market Size, Share, Growth Analysis Report - Forecast 2034

Chemiluminescence Immunoassay Analyzer Market: Industry Perspective

The global chemiluminescence immunoassay analyzer market size was worth around USD 5.80 Billion in 2024 and is predicted to grow to around USD 9.99 Billion by 2034 with a compound annual growth rate (CAGR) of roughly 5.59% between 2025 and 2034.

The report analyzes the global chemiluminescence immunoassay analyzer market's drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the chemiluminescence immunoassay analyzer industry.

Request Free Sample

Chemiluminescence Immunoassay Analyzer Market: Overview

A chemiluminescence immunoassay analyzer is an equipment that is utilized for identifying and monitoring chronic disorders. Furthermore, it plays a key role in in-patient care as it provides doctors with the information they require for identifying and treating a slew of ailments. Reportedly, these medical devices are utilized for diagnosing diseases such as genetic diseases, heart disorders, and contagious diseases. Apart from this, chemiluminescence immunoassay analyzers assist doctors in developing effective modes of medical treatments based on the genetic makeup of each individual. Additionally, the outcomes availed from clinical trials performed on patients by using chemiluminescence immunoassay analyzers enable physicians to understand pathophysiology, etiology, prognosis, illness, and diagnosis.

The chemiluminescence immunoassay analyzer market report is an indispensable guide on growth factors, challenges, restraints, and opportunities in the global market space. The report covers the geographical market along with a comprehensive competitive landscape analysis. It also includes cash flow analysis, profit ratio analysis, market basket analysis, market attractiveness analysis, PESTEL analysis, SWOT analysis, Porter’s five force analysis, and value chain analysis. Additionally, the chemiluminescence immunoassay analyzer industry report explores the investor and stakeholder space to help companies make data-driven decisions.

Key Insights

• As per the analysis shared by our research analyst, the global chemiluminescence immunoassay analyzer market is estimated to grow annually at a CAGR of around 5.59% over the forecast period (2025-2034).
• Regarding revenue, the global chemiluminescence immunoassay analyzer market size was valued at around USD 5.80 Billion in 2024 and is projected to reach USD 9.99 Billion by 2034.
• The chemiluminescence immunoassay analyzer market is projected to grow at a significant rate due to rising prevalence of chronic and infectious diseases, rapid technological advancements in assay development and automation, and increasing demand for accurate, sensitive, and high-throughput diagnostic tools in clinical laboratories and point-of-care sett.
• Based on Type, the High Throughput segment is expected to lead the global market.
• On the basis of Product, the Reagents segment is growing at a high rate and will continue to dominate the global market.
• Based on the Application, the Oncology & Endocrinology segment is projected to swipe the largest market share.
• By End User, the Hospitals & Clinics segment is expected to dominate the global market.
• Based on region, North America is predicted to dominate the global market during the forecast period.

Request Free Sample

Chemiluminescence Immunoassay Analyzer Market: Growth Factors

Rising cases of chronic diseases will embellish the global market surge over 2025-2034

The rise in the occurrence of chronic disorders such as cancer has paved the way for the global chemiluminescence immunoassay analyzer market demand. As per the WHO survey, nearly 9 million deaths occurred due to cancer in 2018. Reportedly, cancer has led to the demise of about 70% of individuals in countries having a large population falling in the range of lower as well as middle income. An increase in the acceptance of completely automated equipment in hospitals, clinics, and various other healthcare units will prompt market trends globally. Large-scale use of products in hepatitis, oncology, retrovirus, endocrinology, and auto-immune disorders will embellish the expansion of the global market.  

A prominent surge in contagious diseases will translate into the massive use of chemiluminescence immunoassay analyzers in hospitals. New product launches will contribute majorly towards the global market size. For instance, in July 2023, Fapon Biotech, a leading player in the life science industry, launched a new chemiluminescence immunoassay system referred to as Shine i8000/9000. Additionally, in November 2022, Getein Biotech, Inc., a Biotech firm based in China, launched new POC solutions that include rapid tests and analyzers. Such moves are likely to boost the expansion of the global market in the ensuing years.

Chemiluminescence Immunoassay Analyzer Market: Restraints

A steep rise in product costs can restrict the global industry expansion over the forecast period

The huge costs of chemiluminescence immunoassay analyzer-based products can impede the growth of the chemiluminescence immunoassay analyzer industry globally. A rise in the maintenance & calibration costs of the product can further put brakes on the global industry surge.  

Chemiluminescence Immunoassay Analyzer Market: Opportunities

Beneficial product features will open new growth opportunities for the global market 

The product provides high throughput and connectivity along with automation, thereby offering new avenues of growth for the global chemiluminescence immunoassay analyzer market. Furthermore, a surge in the demand for point-of-care testing will offer new facets of expansion for the market across the globe. Governments across the globe are allocating massive funds for improving the healthcare infrastructure and this is predicted to drive the global market in the upcoming years.

Chemiluminescence Immunoassay Analyzer Market: Challenges

Low availability of experts can put up a big challenge for the global industry in the near future

The lack of availability of skilled persons can be a challenging task for the global chemiluminescence immunoassay analyzer industry. High prices of equipment can prove to be a daunting task for healthcare professionals and this can prove to be the biggest hurdle in the growth of the industry across the globe.

Chemiluminescence Immunoassay Analyzer Market: Segmentation

The global chemiluminescence immunoassay analyzer market is sectored into product, application, end-use, and region.

Based on Type, the global chemiluminescence immunoassay analyzer market is divided into High Throughput, Medium Throughput, Low Throughput.

In product terms, the global chemiluminescence immunoassay analyzer market is segregated into instruments, software & services, and consumables segments. In addition to this, the consumables segment, which gathered nearly 57% of the global market share in 2022, is anticipated to record the fastest CAGR in the forecast timeline. The growth of the segment in the ensuing years can be attributed to a rise in the demand for consumables including reagents & stains in therapeutic medicine monitoring, disease diagnosis, and endocrinology.  

On the basis of the application, the chemiluminescence immunoassay analyzer industry across the globe is sectored into infectious diseases and oncology segments. Furthermore, the oncology segment, which garnered a notable share of the global industry in 2022, is projected to dominate the application segment in the forecasting years. The segmental surge in the forecast timeline can be owing to a rise in the occurrence of cancer and surging awareness about its diagnosis in developing countries.

Based on the end-use, the global chemiluminescence immunoassay analyzer industry is bifurcated into pharmaceutical & biotech firms, hospitals, and clinical laboratories segments. In addition to this, the hospital segment, which contributed lucratively towards the global market share in 2022, is expected to establish global market dominance in the upcoming years. The segmental surge over the assessment period can be due to the growing preference for the product in hospitals and the increase in hospital visits with a rise in the occurrence of cancer & contagious diseases.

Chemiluminescence Immunoassay Analyzer Market: Report Scope

Chemiluminescence Immunoassay Analyzer Market: Regional Analysis

North America to account for a major share of the global market over the analysis timeline

North America, which accounted for more than half of the global chemiluminescence immunoassay analyzer market share in 2022, is predicted to dominate the global market over the expected timeframe. The market surge in the region over the assessment timeline can be due to the easy availability of well-structured healthcare infrastructure facilities in countries such as the U.S. and Canada. A surge in the allocation of funds by the government for research activities pertaining to chemiluminescence immunoassay analyzers will embellish the regional market growth trends. Moreover, favorable compensation policies will contribute majorly towards regional market expansion. Furthermore, the rise in the geriatric population prone to chronic disorders will shape the growth of the market in the sub-continent.

Furthermore, the chemiluminescence immunoassay analyzer industry in Asia-Pacific is set to register the fastest CAGR in the analysis timeframe. The key growth driving factors of the industry in the region include a surge in awareness about chronic disorders in countries such as India and China. Moreover, the launching of new products by regional players along with the presence of giant players in the region will augment the regional industry expansion.  

Chemiluminescence Immunoassay Analyzer Market: Competitive Analysis

The report provides a company market share analysis to give a broader overview of the key market players. In addition, the report also covers key strategic developments of the market, including acquisitions & mergers, new product launches, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the chemiluminescence immunoassay analyzer market on a global and regional basis.

The global chemiluminescence immunoassay analyzer market is dominated by players like:

• Abbott
• Hoffmann-La Roche Ltd
• Siemens Healthcare GmbH (Siemens AG)
• Danaher (Beckman Coulter Inc.)
• DiaSorin S.p.A.
• Ortho Clinical Diagnostics (Part of Carlyle Group)
• Shenzhen New Industries Biomedical Engineering Co.Ltd.
• Sysmex Corporation
• Randox Laboratories Ltd.
• Tosoh Corporation

The global chemiluminescence immunoassay analyzer market is segmented as follows;

By Type

• High Throughput
• Medium Throughput
• Low Throughput

By Product

• Reagents
• Analyzer
• Consumables

By Application

• Oncology & Endocrinology
• Hepatitis and Retroviruses
• Cardiac Markers
• Infectious Disease
• Bone and Mineral Disorders
• Auto-Immune Diseases
• Allergy
• GI Stool Testing
• Drug Discovery and Deve

By End User

• Hospitals & Clinics
• Medical & Diagnostic Laboratories
• Pharmaceutical Companies

By Region

• North America
  • The U.S.
  • Canada
  • Mexico
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
• The Middle East & Africa
  • Saudi Arabia
  • UAE
  • Egypt
  • Kuwait
  • South Africa
  • Rest of the Middle East & Africa
• Latin America
  • Brazil
  • Argentina
  • Rest of Latin America